136 related articles for article (PubMed ID: 3261712)
1. Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.
Chiou SS; Yamauchi K; Nakanishi T; Obata H
Immunology; 1988 Jul; 64(3):545-50. PubMed ID: 3261712
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
4. Effects of mitogens and lymphokines on the regulation of the immune response to HBs antigen in vitro.
Knöller I; Hoffmann UJ; Werchau HH; König W
Immunology; 1990 Nov; 71(3):352-7. PubMed ID: 2148540
[TBL] [Abstract][Full Text] [Related]
5. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.
Cupps TR; Gerin JL; Purcell RH; Goldsmith PK; Fauci AS
J Clin Invest; 1984 Oct; 74(4):1204-13. PubMed ID: 6332826
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2.
Kakumu S; Fuji A; Tahara H; Yoshioka K; Sakamoto N
J Clin Lab Immunol; 1988 May; 26(1):25-7. PubMed ID: 3263506
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
Bauer T; Jilg W
Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
[TBL] [Abstract][Full Text] [Related]
11. Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro.
Hellström U; Sylvan S; Lundbergh P
J Clin Lab Immunol; 1985 Apr; 16(4):173-81. PubMed ID: 3874965
[TBL] [Abstract][Full Text] [Related]
12. [Antibody responses in human being to pre-S2 and related hepatitis B virus-envelope antigens in vivo and in vitro].
Ogata M; Ishikawa H; Kato Y; Honta S; Yoshida H; Yasuda H; Ohto H; Watanabe N
Rinsho Byori; 1991 Jan; 39(1):3-13. PubMed ID: 1826138
[TBL] [Abstract][Full Text] [Related]
13. Induction of the in vitro anti-HBs response by hepatitis B surface antigen.
Filion LG; Saginur R
Clin Exp Immunol; 1988 Dec; 74(3):321-5. PubMed ID: 2976620
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.
Sam MR; Shokrgozar MA; Shokri F
Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849
[TBL] [Abstract][Full Text] [Related]
15. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
16. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
Sylvan SP; Hellström UB; Lundbergh PR
Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
[TBL] [Abstract][Full Text] [Related]
17. Frequency analysis of HBsAg-specific B lymphocytes in high-responder individuals to recombinant hepatitis B vaccine: comparison of LDA and ELISPOT assays.
Shokrgozar MA; Sam MR; Amirkhani A; Shokri F
Scand J Immunol; 2006 Nov; 64(5):536-43. PubMed ID: 17032247
[TBL] [Abstract][Full Text] [Related]
18. The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.
Wismans PJ; van Hattum J; De Gast GC; Endeman HJ; Poel J; Stolk B; Maikoe T; Mudde GC
Clin Exp Immunol; 1989 Oct; 78(1):75-9. PubMed ID: 2805427
[TBL] [Abstract][Full Text] [Related]
19. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen.
Rahman F; Dahmen A; Herzog-Hauff S; Böcher WO; Galle PR; Löhr HF
Hepatology; 2000 Feb; 31(2):521-7. PubMed ID: 10655280
[TBL] [Abstract][Full Text] [Related]
20. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
